AU2514595A - Prevention of hyperacute rejection in pig to primate organ transplant - Google Patents

Prevention of hyperacute rejection in pig to primate organ transplant

Info

Publication number
AU2514595A
AU2514595A AU25145/95A AU2514595A AU2514595A AU 2514595 A AU2514595 A AU 2514595A AU 25145/95 A AU25145/95 A AU 25145/95A AU 2514595 A AU2514595 A AU 2514595A AU 2514595 A AU2514595 A AU 2514595A
Authority
AU
Australia
Prior art keywords
pig
prevention
organ transplant
hyperacute rejection
primate organ
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU25145/95A
Inventor
Franz A Bieber
Wolfgang Bohm
R. Morton Bolman III
Joseph R Leventhal
Arthur J Matas
Jutta Muller-Derlich
Marc Salit
Reiner Spaethe
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Baxter International Inc
University of Minnesota
Original Assignee
Baxter International Inc
University of Minnesota
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baxter International Inc, University of Minnesota filed Critical Baxter International Inc
Publication of AU2514595A publication Critical patent/AU2514595A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/34—Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration
    • A61M1/3472—Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration with treatment of the filtrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/16—Blood plasma; Blood serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/34—Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration
    • A61M1/3472—Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration with treatment of the filtrate
    • A61M1/3486—Biological, chemical treatment, e.g. chemical precipitation; treatment by absorbents
    • A61M1/3489—Biological, chemical treatment, e.g. chemical precipitation; treatment by absorbents by biological cells, e.g. bioreactor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00—Special media to be introduced, removed or treated
    • A61M2202/04—Liquids
    • A61M2202/0413—Blood
    • A61M2202/0415—Plasma
    • A61M2202/0417—Immunoglobulin
AU25145/95A 1994-05-13 1995-05-12 Prevention of hyperacute rejection in pig to primate organ transplant Abandoned AU2514595A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US242208 1988-09-09
US24220894A 1994-05-13 1994-05-13
PCT/US1995/006028 WO1995031209A1 (en) 1994-05-13 1995-05-12 Prevention of hyperacute rejection in pig to primate organ transplant

Publications (1)

Publication Number Publication Date
AU2514595A true AU2514595A (en) 1995-12-05

Family

ID=22913877

Family Applications (1)

Application Number Title Priority Date Filing Date
AU25145/95A Abandoned AU2514595A (en) 1994-05-13 1995-05-12 Prevention of hyperacute rejection in pig to primate organ transplant

Country Status (3)

Country Link
EP (1) EP0759763A4 (en)
AU (1) AU2514595A (en)
WO (1) WO1995031209A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0804734B1 (en) * 1994-05-13 2005-05-04 Miltenyi Biotec GmbH Sterile and pyrogen-free columns coupled to protein for binding and removal of substances from blood
EP0775493A3 (en) * 1995-11-22 1998-08-12 Baxter International Inc. Extracorporeal xenogeneic organ perfusion following antibody depletion by immunoapheresis
US6464976B1 (en) * 1999-09-07 2002-10-15 Canji, Inc. Methods and compositions for reducing immune response
US20100158893A1 (en) * 2008-12-19 2010-06-24 Baxter International Inc. Systems and methods for obtaining immunoglobulin from blood
AU2013204469B2 (en) * 2008-12-19 2015-04-09 Baxalta GmbH Systems and methods for obtaining immunoglobulin from blood
US20120219633A1 (en) * 2011-02-28 2012-08-30 Pall Corporation Removal of immunoglobulins and leukocytes from biological fluids

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5144013A (en) * 1986-09-24 1992-09-01 Ube Industries, Ltd. Body fluid purifying material and method for purifying body fluid by use thereof
EP0269279A3 (en) * 1986-11-21 1988-09-14 Imre Corporation Extracorporeal removal of immunoglobulin-g and circulating immune complexes
DE69232928D1 (en) * 1991-08-23 2003-03-27 Alberta Res Council METHOD AND COMPOSITIONS FOR PREVENTING THE ANTIBODY-MEDIATED REPELLATION OF XENOGENIC TRANSPLANTS
EP0804734B1 (en) * 1994-05-13 2005-05-04 Miltenyi Biotec GmbH Sterile and pyrogen-free columns coupled to protein for binding and removal of substances from blood

Also Published As

Publication number Publication date
EP0759763A4 (en) 1997-07-30
WO1995031209A1 (en) 1995-11-23
EP0759763A1 (en) 1997-03-05

Similar Documents

Publication Publication Date Title
AU3784193A (en) Reduction of swelling in hemorrhoidal tissues
AU3850395A (en) Hemorrhoidal compositions and method of use
AU2500097A (en) Compositions containing bacteriophages and methods of using bacteriophages to treat infections
AU2371095A (en) Compositions and methods for inhibiting the binding of e-selectin or p-selectin to sialyl-lewisx or sialyl-lewisa
PL333503A1 (en) Compositions of strongly branched primary alcohols and detergents susceptible to biodegradation obtained from such alcohols
AU2113295A (en) Novel compositions and methods for water treatment
AU8143091A (en) Preparation and purification of polylactides
AU4967296A (en) Water stop compositions and methods of preparing same
AU4408593A (en) Methods and activator compositions to disinfect lenses
AU3871093A (en) Surfactant compositions comprising betaine/cocoamide complexes and method of making the same
AU7404494A (en) Methods and compositions for preventing immune rejection of solid organ grafts
AU5605398A (en) Novel methods and compositions for treatment of autoimmune diseases
AU8044491A (en) Antitumor compositions and methods of treatment
AU2514595A (en) Prevention of hyperacute rejection in pig to primate organ transplant
PL331713A1 (en) Azacycloalkylkanoylpeptides and pseudopeptides acting as antithrombotic agents
AU8192691A (en) Method of treatment and compositions therefore
HUP9904332A3 (en) Compositions and articles of manufacture
AU7894591A (en) Composition against ozone damages to cultivations and method for its application
EP0966196A4 (en) Composition for organ cryopreservation and treatment of viral and bacterial infections
GB9200284D0 (en) Suppression of"organ pipes"raster display distortions
ZA9510785B (en) Use of lauric esters as activity-increasing substa
AU5456898A (en) Compositions and articles of manufacture
AU649294B2 (en) Phosphate esters and compositions containing them
PL314588A1 (en) Application of pentoxyphyline in treatment of sclerosis multiplex
AU4709993A (en) Islets of Langerhan's in pure form